These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 20561324
1. Disparate risks and effects of pooled whole blood-derived vs. apheresis platelet production require an integral view on the blood supply. Zimmermann R, Blasczyk R, Zingsem J, Eckstein R, Heuft HG. Vox Sang; 2010 Oct; 99(3):295-6; author reply 297-8. PubMed ID: 20561324 [No Abstract] [Full Text] [Related]
2. The ethics of wasting the donor's gift of buffy coat. Vamvakas EC. Vox Sang; 2011 Feb; 100(2):256-7; author reply 258-9. PubMed ID: 20825600 [No Abstract] [Full Text] [Related]
3. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Schrezenmeier H, Seifried E. Vox Sang; 2010 Jul 01; 99(1):1-15. PubMed ID: 20059760 [Abstract] [Full Text] [Related]
4. A critical comparison of platelet preparation methods. Vassallo RR, Murphy S. Curr Opin Hematol; 2006 Sep 01; 13(5):323-30. PubMed ID: 16888436 [Abstract] [Full Text] [Related]
5. Platelet concentrates, from whole blood or collected by apheresis? van der Meer PF. Transfus Apher Sci; 2013 Apr 01; 48(2):129-31. PubMed ID: 23535511 [Abstract] [Full Text] [Related]
6. Pooled platelet concentrates: an alternative to single donor apheresis platelets? Pietersz RN. Transfus Apher Sci; 2009 Oct 01; 41(2):115-9. PubMed ID: 19716340 [Abstract] [Full Text] [Related]
7. Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120. Ifran A, Haşimi A, Kaptan K, Nevruz O, Beyan C, Erbil K. Transfus Apher Sci; 2005 Oct 01; 33(2):87-90. PubMed ID: 16139569 [Abstract] [Full Text] [Related]
8. The hemostatic efficacy of platelet components prepared with pathogen inactivation. Corash L. Transfusion; 2011 Jun 01; 51(6):1355-6; author reply 1356-7. PubMed ID: 21658040 [No Abstract] [Full Text] [Related]
10. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis. Thiele T, Alt-Mayer T, Greinacher A, Bux J. Vox Sang; 2016 Nov 01; 111(4):350-356. PubMed ID: 27432635 [Abstract] [Full Text] [Related]
11. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators. Fontana S, Mordasini L, Keller P, Taleghani BM. Transfusion; 2006 Nov 01; 46(11):2004-10. PubMed ID: 17076857 [Abstract] [Full Text] [Related]
12. [Study of the platelet concentrate obtained with the MCS cell separator of the Society of Haemonetics]. Schooneman F. Ann Med Interne (Paris); 1994 Nov 01; 145(5):345-9. PubMed ID: 7985946 [Abstract] [Full Text] [Related]
14. Hemoglobin and platelet count effect on platelet yields in plateletpheresis. Guerrero-Rivera S, Gutiérrez-Espíndola G, Talavera JO, Meillón-García LA, Pedraza-Echevarría M, Pizzuto-Chávez J. Arch Med Res; 2003 Nov 01; 34(2):120-3. PubMed ID: 12700007 [Abstract] [Full Text] [Related]
17. A comparison of washed and volume-reduced platelets with respect to platelet activation, aggregation, and plasma protein removal. Veeraputhiran M, Ware J, Dent J, Bornhorst J, Post G, Cottler-Fox M, Pesek G, Theus J, Nakagawa M. Transfusion; 2011 May 01; 51(5):1030-6. PubMed ID: 20946201 [Abstract] [Full Text] [Related]
20. A prospective quality evaluation of single donor platelets (SDP) - an experience of a tertiary healthcare center in India. Pandey P, Tiwari AK, Sharma J, Singh MB, Dixit S, Raina V. Transfus Apher Sci; 2012 Apr 01; 46(2):163-7. PubMed ID: 22365925 [Abstract] [Full Text] [Related] Page: [Next] [New Search]